- Home
- J&J Innovative Medicine
J&J Innovative Medicine
What you need to know about the coronavirus—and a potential preventive vaccine
The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.
What you need to know about Johnson & Johnson’s 2019 fourth-quarter and full-year earnings report
Check out this infographic breakdown of the company’s fourth quarter and annual earnings report, with key performance highlights from its pharmaceutical, consumer and medical devices businesses.
Johnson & Johnson named a 2020 Fortune World’s Most Admired Company.
Innovativeness and a commitment to social responsibility are just some of the respected attributes that helped the company land on the prestigious list for another year.
Alzheimer’s disease: Why one company refuses to give up the search for a cure
It’s the sixth leading cause of death in the United States, with no existing cure. But these researchers are committed to finding better ways to diagnose, treat and prevent the debilitating disease, using everything from innovative biomarker tracking to a potential vaccine for early stage patients.
I have a vision for helping advance healthcare: Meet 6 leaders working on inspiring innovations in 2020
From robotics solutions for orthopedic surgery to the potential to bring new hope to patients living with multiple myeloma through CAR-T, these are just some of the cutting-edge projects that these visionaries think could potentially help propel healthcare forward around the globe.
“I’m driven by the knowledge of the difference we can make": Meet 10 scientists who really inspired us in 2019.
A groundbreaking trial for an HIV vaccine. New ways to help the body heal itself. Immunotherapy treatments for cancer. Behind medical advancements like these are the brilliant scientists who are relentlessly pushing their visions and research forward.
3 innovative ways researchers are rethinking how we combat the flu
From a promising alternative for the flu shot to hope for a “universal” vaccine, we take a look at how scientists at Johnson & Johnson are exploring novel ideas for preventing and treating the flu.
Combating Ebola: How a Johnson & Johnson vaccine is helping in the fight
The company has committed to donate up to 500,000 doses of an investigational Janssen vaccine regimen to help protect citizens of the Democratic Republic of the Congo—the site of the world’s second largest outbreak of the disease.
What you need to know about Johnson & Johnson’s 2019 third-quarter earnings
Check out this infographic breakdown of the company’s third-quarter performance, with key highlights from its consumer, pharmaceutical and medical devices businesses.
3 ways Johnson & Johnson is working to create a more diverse and inclusive workplace—and world
The company just released its inaugural Diversity & Inclusion Impact Review. We take a look inside its pages to see how the company’s striving every day to build a culture of belonging.